Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-31

Clinical Trial Update: Post Discharge Human Milk Fortifier in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating post-discharge human milk fortifier in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Post Discharge Human Milk Fortifier

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Infant, Low Birth Weight | Phase 2 | Status: COMPLETED